Moonlighting of Helicobacter Pylori Catalase Protects Against Complement-mediated Killing by Utilising the Host Molecule Vitronectin
Authors
Affiliations
Helicobacter pylori is an important human pathogen and a common cause of peptic ulcers and gastric cancer. Despite H. pylori provoking strong innate and adaptive immune responses, the bacterium is able to successfully establish long-term infections. Vitronectin (Vn), a component of both the extracellular matrix and plasma, is involved in many physiological processes, including regulation of the complement system. The aim of this study was to define a receptor in H. pylori that binds Vn and determine the significance of the interaction for virulence. Surprisingly, by using proteomics, we found that the hydrogen peroxide-neutralizing enzyme catalase KatA is a major Vn-binding protein. Deletion of the katA gene in three different strains resulted in impaired binding of Vn. Recombinant KatA was generated and shown to bind with high affinity to a region between heparin-binding domain 2 and 3 of Vn that differs from previously characterised bacterial binding sites on the molecule. In terms of function, KatA protected H. pylori from complement-mediated killing in a Vn-dependent manner. Taken together, the virulence factor KatA is a Vn-binding protein that moonlights on the surface of H. pylori to promote bacterial evasion of host innate immunity.
Glorieux C, Buc Calderon P Redox Biol. 2024; 77:103404.
PMID: 39447253 PMC: 11539659. DOI: 10.1016/j.redox.2024.103404.
Recruitment of Vitronectin by Bacterial Pathogens: A Comprehensive Overview.
Pellegrini A, Pietrocola G Microorganisms. 2024; 12(7).
PMID: 39065153 PMC: 11278874. DOI: 10.3390/microorganisms12071385.
The immunopathogenesis of -induced gastric cancer: a narrative review.
Shirani M, Shariati S, Bazdar M, Sojoudi Ghamnak F, Moradi M, Shams Khozani R Front Microbiol. 2024; 15:1395403.
PMID: 39035439 PMC: 11258019. DOI: 10.3389/fmicb.2024.1395403.
Microbial evasion of the complement system: a continuous and evolving story.
Heggi M, Nour El-Din H, Morsy D, Abdelaziz N, Attia A Front Immunol. 2024; 14:1281096.
PMID: 38239357 PMC: 10794618. DOI: 10.3389/fimmu.2023.1281096.
Al-Fakhrany O, Elekhnawy E Arch Microbiol. 2023; 205(9):301.
PMID: 37550555 PMC: 10406680. DOI: 10.1007/s00203-023-03639-0.